Saliva-based serology assays that measure antibodies against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antigens are important coronavirus disease 2019 (COVID-19) markers. Serology ...

Multiple commercial assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies have been approved for use as serological tests by Health Canada, with some manufacturers ...

The coronavirus disease 2019 (COVID-19) pandemic brought about by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already led to four major waves of infection in Canada. Reports ...

-Patient Data Demonstrates Validity of Novel Imaging-Based Approach Furthering Capricor’s Platform Advancement- LOS ANGELES, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR ...

New serology assay accelerates COVID-19 research and vaccine development through rapid characterization of human immune response to multiple SARS-CoV-2 antigens MINNEAPOLIS, Oct. 19, 2020 /PRNewswire/ ...

At the root of almost every plan to restart society is a new kind of coronavirus test that searches not for the virus itself, but the remnants floating in people’s blood of the battle between their ...

SARS-CoV-2 has created significant challenges for laboratories, requiring the development, validation, and scale up of testing in a very short time period--often this was done for multiple methods due ...

The test has also met the CE mark requirements for Europe. Clinical evaluation of the SARS-CoV-2 Total Ab test has demonstrated diagnostic specificity of more than 99 percent and diagnostic ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Bio-Plex Pro Human IgG SARS-CoV-2 N/RBD/S1 ...

BREA, Calif., April 22, 2020 /PRNewswire/ -- Building on its strong commitment to the fight against coronavirus (COVID-19), Beckman Coulter today announced a mid-May launch timeline for its new Access ...

LOS ANGELES, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the discovery, development and commercialization of ...